The Endocrine Society has not published specific guidelines on peptide-fragment overdose management, though their 2019 growth hormone therapy guidelines provide the closest clinical framework for assessing GH-axis perturbation in overdose contexts [11]
Five stages of evolving -cell dysfunction during progression to diabetes
Jan 2018;37(1):60-70
Additional information How to cite this article: Noonan, F.P
In addition, the chronic expression of the vector protein S gene, in individuals carrying certain HLA haplotypes, could induce immune hyperactivation and excessive production of proinflammatory cytokines, leading to autoimmune hypophysitis or inhibition of ACTH secretion (functional hypopituitarism) (62)
If you're moving off a compounded GLP-1 medication specifically, it's worth talking to your new provider first, since the exact dose you were taking may not be clear